You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

A2A Receptor antagonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Spinal Cord Injuries, Myelopathy Trial in Cambridge (Istradefylline, low oxygen therapy)

Not yet recruiting
  • Spinal Cord Injuries
  • Myelopathy
  • Cambridge, Massachusetts
    Spaulding Rehabilitation Hospital
Jun 24, 2022

Carcinoma, Non-small-Cell Lung Trial in New York, Fairfax (JNJ-86974680, Cetrelimab, Radiation Therapy)

Recruiting
  • Carcinoma, Non-small-Cell Lung
  • New York, New York
  • +1 more
Nov 8, 2023

Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)

Recruiting
  • Safety Issues
  • +2 more
  • Washington, District of Columbia
    Georgetown University
Dec 1, 2022

s to Learn More About Treatment With Steroidal Mineralocorticoid

Active, not recruiting
  • Chronic Kidney Disease
  • +2 more
  • sMRA therapies
  • Whippany, New Jersey
    Many Locations
Jan 30, 2023

In-stent Restenosis Trial in Beijing (Colchicine, Prednisone, Aspirin)

Not yet recruiting
  • In-stent Restenosis
  • Beijing, Beijing, China
    Fuwai Hospital
Oct 15, 2023

Neuroendocrine Neoplasia's (NENs), Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) Trial in Basel (161Tb-DOTA-LM3,

Not yet recruiting
  • Neuroendocrine Neoplasia's (NENs)
  • Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
  • Basel, Switzerland
    Division of Nuclear Medicine, University Hospital Basel
Apr 27, 2022

Chronic Pain Trial in Berlin (MEDI0618, Placebo)

Recruiting
  • Chronic Pain
  • Berlin, Germany
    Research Site
Jan 26, 2023

Pancreatitis, Acute Trial in Denmark, Sweden (Placebo treatment, Naldemedine 0.2 MG Oral Tablet)

Recruiting
  • Pancreatitis, Acute
  • Placebo treatment
  • Naldemedine 0.2 MG Oral Tablet
  • Aalborg, Jutland, Denmark
  • +4 more
Mar 7, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Adenosine A2B Receptor Antagonist PBF-1129
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 1, 2023

Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

Enrolling by invitation
  • Chronic Kidney Diseases
  • Aurora, Colorado
  • +5 more
Oct 18, 2022

Malignant Solid Tumor Trial in Nashville (Ifetroban Sodium, Placebo)

Recruiting
  • Malignant Solid Tumor
  • Ifetroban Sodium
  • Placebo
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jun 23, 2022

Breast Carcinoma, Estrogen Receptor Positive Trial in Palo Alto (drug, procedure, device)

Suspended
  • Breast Carcinoma
  • Estrogen Receptor Positive
  • Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
  • +3 more
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Dec 8, 2021

COVID-19 Pneumonia Trial in Szczecin (Canrenoate Potassium, Normal Saline)

Recruiting
  • COVID-19 Pneumonia
  • Canrenoate Potassium
  • Normal Saline
  • Szczecin, Poland
    Pomeranian Medical University
Jun 3, 2021

Diabetic Kidney Disease Trial in Australia (SER150, Placebo)

Recruiting
  • Diabetic Kidney Disease
  • Liverpool, New South Wales, Australia
  • +6 more
May 17, 2022

H2 Receptor Antagonist and Proton Pump Inhibitor on Positivity

Not yet recruiting
  • COVID-19
  • No intervention (Retrospective Cohort Observational)
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Apr 6, 2021

Drug Interaction Trial in Brisbane (Telaglenastat, Famotidine, Placebo for famotidine)

Completed
  • Drug Interaction
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane Clinic (formerly Q-Pharm)
Mar 8, 2021

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Nashville (Atezolizumab, Cobimetinib,

Terminated
Has Results
  • Stage III Breast Cancer
  • +6 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Aug 10, 2021

Metastatic Castrate-resistant Prostate Cancer, Adenocarcinoma, Prostate Trial in United States (TRC253)

Completed
Has Results
  • Metastatic Castrate-resistant Prostate Cancer
  • Adenocarcinoma, Prostate
  • Birmingham, Alabama
  • +4 more
Mar 29, 2021

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +3 more
Jan 17, 2023

Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)

Completed
Has Results
  • Epidermolysis Bullosa
  • Serlopitant Tablet
  • Placebo Oral Tablet
  • Redwood City, California
    Stanford University
Nov 30, 2022

Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic Trial in San Francisco, Salisbury (Suvorexant,

Recruiting
  • Sleep Initiation and Maintenance Disorders
  • Stress Disorders, Posttraumatic
  • San Francisco, California
  • +1 more
Nov 10, 2022

Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)

Recruiting
  • Adamantinomatous Craniopharyngioma
  • Recurrent Adamantinomatous Craniopharyngioma
  • Aurora, Colorado
  • +17 more
Jan 8, 2023

Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

Recruiting
  • Rectal Cancer
  • Kineret 100 MG in 0.67 ML Prefilled Syringe
  • +3 more
  • Frankfurt, Germany
    University Hospital Goethe University Frankfurt
Aug 23, 2022